K183266 is an FDA 510(k) clearance for the EP-TRACER System. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.
Submitted by Schwarzer Cardiotek GmbH (Heilbronn, DE). The FDA issued a Cleared decision on March 1, 2019 after a review of 98 days - within the typical 510(k) review window.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.